Completed PHASE4 INTERVENTIONAL 4-arm NCT03068897

Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain

Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain: A Randomized Trial

Sponsor: Montefiore Medical Center

Interventions Baclofen Educational intervention Ibuprofen 600 mg Metaxalone Tizanidine

Updated 11 times since 2017 Last updated: Aug 11, 2020 Started: May 3, 2017 Primary completion: Jul 11, 2018 Completion: Oct 11, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03068897, this PHASE4 trial focuses on Low Back Pain and remains completed. Sponsored by Montefiore Medical Center, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4

▶ Show 6 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE4
Sep 2020 — Jan 2021 [monthly]

Completed PHASE4
Dec 2018 — Sep 2020 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE4
Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Mar 2017 — Jun 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Montefiore Medical Center

Data source: Montefiore Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• The Bronx, United States